ResearcherShanghai Jiao Tong UniversityNo recent work listed
Min-Juan Xu
Matched on ORCID iD 0000-0003-1768-208X; OpenAlex author ID A5083207380.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 5
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper
Papers 2
- Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2. Last author DOI 10.1096/fj.201901237r↗
- Structural diversity of anti-pancreatic cancer capsimycins identified in mangrove-derived Streptomyces xiamenensis 318 and post-modification via a novel cytoch… Last author DOI 10.1038/srep40689↗
Closest collaborators
The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Zhigang Zhang · 2 shared papers, 2017–2020
- Xiaomei Yang · 2 shared papers, 2017–2020
- Shu-Heng Jiang · 2 shared papers, 2017–2020
- Yongwei Sun · 1 shared paper, 2020
- Helin Yu · 1 shared paper, 2017
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.